BioSpace News Archive

Hand hygiene management system protects against the threat and spread of illness with a hand scanner that tracks handwashing frequency and effectiveness

Presentations and e-publications from SCCA clinicians to feature the latest research on breast, gastrointestinal, genitourinary, lung, renal and sarcoma cancers, and hematological malignancies SEATTLE--( BUSINESS WIRE )-- Seattle Cancer Care Alliance (SCCA) , announced today the new findings from its clinicians that will be featured at the 2020 American Society of Clinical Oncology (ASCO) Virtual Scientific Program May 29-31, 2020. SCCA clinic

Bioinsider LLC (Bioinsider), a company dedicated to creating a quality, unbiased virtual meeting platform for communication among the scientific, policymaker and business communities, has opened registration and a call for speaker proposals for its four-part virtual meeting series, Together as One COVID-19 Series.

CTCA remains fully operational for all cancer care to flatten curve and launches online risk assessment, Alexa Skill and COVID-19 Cancer Chatbot to help people virtually [21-May-2020] BOCA RATON, Fla. , May 21, 2020 /PRNewswire/ -- The COVID-19 pandemic has caused disruption in oncology care and is creating a cancer " shadow curve " that may result in a dramatic spike

According to Ryan J. Foley , President and CEO of Canadian based NuvoCare Health Sciences Inc. and i2 New ltd. out of Ireland , “NuvoCare stands behind all of the products we sell. NuvoCare is keen to work with the Commissioner and Competition Bureau to ensure that the representations it makes into the public do not raise issues under the

Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced its first quarter 2020 financial results.

Progress Reported in Both Proprietary and Partnered Neurology Clinical Programs Additional FDA Feedback Supports Commencement of XEN496 Phase 3 Clinical Trial in 2020 Conference Call at 4:30 pm ET Today BURNABY, British Columbia, May 21, 2020 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today reported its financial results for first quarter ended March 31, 2020 and provided a corporate update. Dr. Simon Pimstone, Xe

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that due to the public health impact of the novel coronavirus (COVID-19) outbreak and governmental restrictions limiting the number of people who may gather together, and to

Battelle has honored Satya Chauhan as its Inventor of the Year and Kavitha Dasu as its most recent Emerging Scientist.

Abbott (NYSE: ABT) announced today an interim analysis of an ongoing multi-site clinical study in urgent care clinics that indicates its ID NOW COVID-19 rapid test is showing strong agreement to lab-based molecular polymerase chain reaction (PCR) instruments.